C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/78 (2006.01) A61K 31/17 (2006.01) A61K 31/33 (2006.01) A61K 31/535 (2006.01) A61K 31/54 (2006.01) C07C 275/20 (2006.01) C07C 275/22 (2006.01) C07C 275/24 (2006.01) C07C 275/28 (2006.01) C07C 275/30 (2006.01) C07C 275/32 (2006.01) C07C 275/36 (2006.01) C07C 275/40 (2006.01) C07C 311/29 (2006.01) C07C 317/22 (2006.01) C07D 209/48 (2006.01) C07D 211/72 (2006.01) C07D 213/75 (2006.01) C07D 213/81 (2006.01) C07D 295/13 (2006.01) C07D 295/135 (2006.01) C07D 295/192 (2006.01)
Patent
CA 2359510
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
La présente invention concerne l'utilisation d'un groupe d'arylurées dans le traitement de maladies liées à la présence de kinase raf, ainsi que des compositions pharmaceutiques destinées à être utilisées dans de telles thérapies.
Dumas Jacques
Khire Uday
Lowinger Timothy B.
Monahan Mary-Katherine
Natero Reina
Bayer Healthcare Llc
Corporation Bayer
Smart & Biggar
LandOfFree
.omega.-carboxyaryl substituted diphenyl ureas as raf kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .omega.-carboxyaryl substituted diphenyl ureas as raf kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .omega.-carboxyaryl substituted diphenyl ureas as raf kinase... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1666797